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Abstract: Stroke is a polygenic disorder. Previous genetic studies focused on candidate genes influencing pathogenic 
processes, with little emphasis on genes influencing vascular risk factors. Previous research linked the ClC-Kb
T481S
 poly-
morphism to blood pressure (BP). We therefore undertook an association study to determine the relevance of this poly-
morphism to stroke, particularly lacunar stroke, given its strong correlation with hypertension. We genotyped DNA from 
180 patients with acute ischaemic stroke (44 having lacunar stroke) and 298 age- and gender-matched controls using a se-
quence-specific polymerase chain reaction method (SS-PCR). We found no association between the ClC-Kb
T481S
 poly-
morphism and ischaemic stroke (Odds Ratio (OR): 0.87, 95% Confidence Interval (CI): 0.57-1.33). Stratification for 
stroke subtype did not alter this finding. This polymorphism showed a borderline association with history of hypertension 
(p=0.06) but was not associated with systolic or diastolic BP (p>0.05). To our knowledge there are no other studies pub-
lished on this polymorphism and stroke. 
INTRODUCTION 
Previous genetic studies on stroke patients considered candi-
date genes that influence pathogenic processes, with little 
emphasis on genes that influence vascular risk factors. 
 The ClC-Kb
T481S
 polymorphism causes a threonine to 
serine amino acid substitution at position 481 of the renal 
tubule chloride channel ClC-Kb protein, resulting in en-
hanced activity and renal salt retention [1]. A previous study 
reported an association with hypertensive BP levels [2]. 
Therefore, given the strong positive association between BP 
and stroke [3,4], particularly of lacunar stroke with hyperten-
sion [5], we initiated an association study to determine the 
relevance of this polymorphism to stroke. 
 Our aim was to determine the relevance of this chloride 
channel polymorphism to (a) ischaemic stroke, (b) lacunar 
stroke, (c) BP and (d) hypertension. To our knowledge, this 
is the first study to investigate the association between this 
polymorphism and stroke. 
MATERIALS AND METHODS 
 We genotyped DNA from 180 acute ischaemic stroke 
patients (44 with lacunar stroke) and 298 age- and gender-
matched controls, sourced from our earlier prospective case-
control study, using the same method [6]. Research ethics 
approval was obtained. All participants had been assessed 
for known cerebrovascular risk factors including age, gender, 
ethnicity, family history of stroke, cigarette smoking, hyper-
cholesterolemia, hypertension, diabetes and atrial fibrillation.  
 Hypertension was defined as a history of hypertension, 
on treatment for hypertension, or BP>140mm Hg systolic or  
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>90mm Hg diastolic [6]. Stroke subtype was determined 
using Oxfordshire Community Stroke Project criteria [7] and 
brain Computerised Tomography or Magnetic Resonance 
Imaging. 
 The two forward allele-specific primers were wild-type 
(A) CAGGGGCTGTGACCCACA and mutant (T) CAG 
GGGCTGTGACCCACT, while the sequence of the reverse 
consensus primer was AGAACAGAGCACAGCTGTGT 
(from Genbank Accession Number NT_004873.16, accessed 
7/10/2004, synthesized by GeneWorks Pty Ltd, South Aus-
tralia). The detected SNP sequence was confirmed by se-
quence analysis. The 338 base-pair fragment around the 
ClC-Kb
T481S
 polymorphism was amplified from the extracted 
DNA, using the SS-PCR method [8]. Amplified products 
were examined by gel electrophoresis, with a positive con-
trol (DRB1 HLA primer) in each reaction mix, as previously 
described [6], and negative controls in every run. Only gel 
results with a positive control band present were accepted; 
any banding in the negative controls resulted in the entire 
assay being repeated. Genotypes were determined by visual 
inspection by a single trained reader (AGM).  
STATISTICAL ANALYSIS 
 Logistic regression was used to determine the risk of 
ischaemic stroke associated with the ClC-Kb
T481S
 polymor-
phism for all stroke patients and, following stratification, for 
stroke subtype [6]. The association between the ClC-Kb
T481S
 
polymorphism and BP was determined using a 2–sample t–
test, and between the polymorphism and hypertension using 
Pearson’s Chi-square analysis. Hardy-Weinberg equilibrium 
was assessed. 
 Using the minor allele population frequency of 12.4% 
[2], power was calculated using Win Episcope (ver. 
2, http://www.clive.ed.ac.uk/winepiscope/). For 95% confi-
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dence levels and 80% beta, 471 subjects were required to 
detect a minimum odds ratio of 2.0. 
RESULTS 
 Analysis was performed on 180 patients and 298 controls 
from whom DNA was available. Allelic frequencies were in 
Hardy-Weinberg equilibrium (Chi-square<3.841, p>0.05). 
Full study demographics and risk factor characteristics de-
scribed previously showed no significant difference between 
patients and controls for vascular risk factors [6]. Control 
allelic frequencies (14.1%) were reported previously [9]. 
Data for the whole study group (n=478) as well as the lacu-
nar stroke subset of patients is presented in Table 1. The 
odds ratio confidence intervals encompass unity; hence the 
data offer no evidence that the odds of stroke are influenced 
by this chloride channel genotype. Adjustment for the cere-
brovascular risk factors cited above did not alter the out-
come.  
 We found that the ClC-Kb
T481S
 polymorphism demon-
strated a borderline association with the sub-group that had a 
history of hypertension (Table 2; p=0.06), but no association 
with the larger above-defined hypertension group. We also 
found no association with either systolic BP or diastolic BP 
(Table 3; p>0.05). 
Table 2. Association of the ClC-Kb
T481S
 Gene Polymorphism 
with the ‘History of Hypertension’ Sub-Group. 
Nil History of 
Hypertension 







n (%) n (%) p 
AA 175 (70) 178 (78) 
AT or TT 74 (30) 51 (22) 
0.06 
Totals 249 (100) 229 (100)  
 
Table 3. Association of the ClC-Kb
T481S
 Gene Polymorphism 
with Mean BP (mm of Mercury) 




Systolic Diastolic p 
AA 148 (27) 78 (12) 0.69 
AT or TT 147 (24) 77 (12) 0.69 
 
DISCUSSION 
 Our novel association study sought to determine the rele-
vance of the ClC-Kb
T481S
 polymorphism to stroke. We also 
sought to clarify any link between this polymorphism and 
either current BP or history of hypertension in view of the 
varied findings of other studies [2,10-12]. Our study found 
no association between the ClC-Kb
T481S
 polymorphism and 
ischaemic stroke or, following stratification, lacunar stroke. 
We also found that this polymorphism is not a predictor of 
BP or hypertension, although there may be some trend to-
wards hypertension, demonstrated by the borderline associa-
tion with the sub-group that had a history of hypertension 
(Table 2, p = 0.06). 
 The lack of association with BP or hypertension contrasts 
with previous positive findings in Jeck’s paper on a smaller 
sample of 220 subjects in Tübingen, Germany [2]. They re-
ported a significant association of the T allele with higher BP 
(~6.0 and ~4.2 mm Hg systolic and diastolic, respectively) 
and an allelic frequency of 12.4% in whites in their study 
[2,13]. We found a similar allelic frequency (14.1%) in our 
controls [9]. However, the small size of their study popula-
tion leaves room for uncertainty [13]. Our findings agree 
with a recent study of larger sample size and add further evi-
dence that this polymorphism is not a predictor of BP [12]. 
 Jeck also reported a higher prevalence of hypertensive 
BP levels and postulated that this polymorphism predisposed 
to the development of essential hypertension [2]. Several 
more recent studies with larger sample groups have not 
found a link with hypertension [10-12]. Our data appears to 
confirm this observation. However, the borderline probabil-
ity value of the association with hypertension (Table 2, 
p=0.06) may reflect the earlier observation by Jeck’s group 
of a ‘predisposition’ to hypertension [2]. This may be worthy 
of further investigation with a larger population group. Nev-
ertheless, the overall lack of association with BP or hyper-
tension would provide a plausible biological explanation for 
the lack of association with stroke that we observed. 
 With respect to sample size, we were sufficiently pow-
ered to detect an association with BP, hypertension or stroke, 
although not for individual stroke subtypes. A limitation to 
our study is the lack of exclusion of some confounders, e.g. 
diuretics. Since the aim of the original study was unrelated to 
diuretic use, this data was not collected. Other limitations in 
our cohort have been addressed previously [6]. 
CONCLUSIONS 
 In this first study seeking a link between the ClC-Kb
T481S
 
gene polymorphism and stroke, we found no association 
Table 1. Association of the ClC-Kb
T481S
 Gene Polymorphism with Ischaemic and Lacunar Stroke Patients. Values represent the 
number of subjects (percentage of subjects in parentheses), Odds Ratio (O.R.) with 95% confidence intervals and prob-
ability (p) values 




n (%) n (%) O.R. 95% C.I. p n (%) O.R. 95% C.I. p 
AA 217 (73) 136 (76) 34 (77) 
AT or TT 81 (27) 44 (24) 
0.87 0.57 – 1.33 0.51 
10 (23) 
0.79 0.37 – 1.66 0.53 
Totals 298 (100) 180 (100)    44 (100)    
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between this polymorphism and increased risk of ischaemic 
stroke. The ClC-Kb
T481S
 polymorphism is also not a predic-
tor of BP. However, there may be a weak association with 
hypertension. We suggest that if an association with lacunar 
stroke is to be explored further, studies of larger sample size 
are required. Such studies may also clarify whether there is a 
link with hypertension. Furthermore, other genetic influences 
may play a role and therefore warrant further investigation. 
To our knowledge there are no other studies published on 
this polymorphism and stroke.  
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